Article metrics

Download PDFPDF

841 LBL-019, a novel TNFR2 agonist antibody, shows potent anti-tumor efficacy through preferentially activating CD8+ T cells and alleviating the suppressive effect of Treg cells

 

Online download statistics by month:

Online download statistics by month: November 2023 to September 2024

AbstractFullPdf
Nov 2023128012
Dec 202332010
Jan 20242904
Feb 20244005
Mar 20243406
Apr 202410011
May 202420017
Jun 20243406
Jul 202448013
Aug 20241606
Sep 20242205
Total413095